Subtilisin variants having improved stability

US12509672B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12509672-B2
Application numberUS-201917295959-A
CountryUS
Kind codeB2
Filing dateNov 25, 2019
Priority dateNov 28, 2018
Publication dateDec 30, 2025
Grant dateDec 30, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein is one or more subtilisin variant, nucleic acid encoding same, and compositions and methods related to the production and use thereof, including one or more subtilisin variant that has improved stability compared to one or more reference subtilisin.

First claim

Opening claim text (preview).

We claim: 1 . A subtilisin variant having subtilisin protease activity and sharing at least 70% amino acid sequence identity with any one of SEQ ID NO: 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 22, wherein the variant comprises the mutations X040E, X078N, and X166Q, wherein the positions are numbered by correspondence with the amino acid sequence of SEQ ID NO: 1, wherein the variant does not have 100% sequence identity to a naturally-occurring amino acid sequence. 2 . The subtilisin variant of claim 1 , wherein the variant has at least one, two, or more additional mutations selected from the group consisting of X003V, X009E, X024Q, X069S, X076D, X079I, X087D, X118R, X124I, X128S, X129P, X130S, X145R, X182E, X185Q, X210I, X217L, X218S, X248D, and X259P, wherein the positions are numbered by correspondence with the amino acid sequence of SEQ ID NO: 1, wherein the variant does not have 100% sequence identity to a naturally-occurring amino acid sequence. 3 . The subtilisin variant of claim 1 , wherein said variant is derived from a parent or reference polypeptide sharing at least 70%, 75%, 80%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% amino acid sequence identity with any one of SEQ ID NO: 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 22. 4 . The subtilisin variant of claim 1 , wherein said variant comprises an amino acid sequence sharing at least 75%, 80%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% amino acid sequence identity with any one of SEQ ID NO: 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 22. 5 . The subtilisin variant of claim 1 , wherein said variant has improved stability when compared to a reference subtilisin lacking the mutations X040E, X078N, and X166Q numbered by correspondence with the amino acid sequence of SEQ ID NO: 1. 6 . The subtilisin variant of claim 5 , wherein the improved stability is measured as (i) a performance index (PI) of 1.1 or greater after 20 minutes at 30-70 degrees Celsius in a 10% detergent solution in comparison to a respective parent from which the variant is derived or (ii) an improved residual activity of at least 10% greater in comparison to the respective parent from which the variant is derived under the same assay conditions. 7 . The subtilisin variant of claim 6 , wherein the improved stability is measured as (i) a PI of 1.1 or greater after 20 minutes at 30-70 degrees Celsius in 10% detergent solution without protease-stabilizers in comparison to the respective parent from which the variant is derived or (ii) an improved residual activity of at least 10% greater in comparison to the respective parent from which the variant is derived under the same assay conditions in a 10% detergent solution without protease-stabilizers. 8 . The subtilisin variant of claim 1 , wherein the subtilisin variant has a cleaning performance index (PI) value of 1.0 or greater in comparison to a reference subtilisin. 9 . A polynucleotide comprising a nucleotide sequence that encodes the subtilisin variant of claim 1 , wherein said polynucleotide is optionally isolated. 10 . An expression vector or cassette comprising the polynucleotide of claim 9 . 11 . The expression vector or cassette of claim 10 , wherein the polynucleotide is operably linked to a promoter. 12 . A recombinant host cell comprising the expression vector or cassette of claim 10 . 13 . A composition comprising one or more subtilisin variant according to claim 1 . 14 . The composition according to claim 13 , wherein said composition is selected from the group consisting of an enzyme composition and a detergent composition. 15 . The composition according to claim 14 , wherein said detergent composition is selected from the group consisting of a laundry detergent, a fabric softening detergent, a dishwashing detergent, and a hard-surface cleaning product. 16 . The composition of claim 13 , wherein said composition further comprises one or more ions selected from calcium and/or zinc; one or more enzyme stabilizer from 0.001 to 1.0 weight % of said subtilisin variant; one or more bleaching agent; one or more adjunct material; and/or one or more additional enzymes or enzyme derivatives selected from the group consisting of acyl transferases, alpha-amylases, beta-amylases, alpha-galactosidases, arabinosidases, aryl esterases, beta-galactosidases, carrageenases, catalases, cellobiohydrolases, cellulases, chondroitinases, cutinases, DNase or nuclease, endo-beta-1, 4-glucanases, endo-beta-mannanases, esterases, exo-mannanases, galactanases, glucoamylases, hemicellulases, hyaluronidases, keratinases, laccases, lactases, ligninases, lipases, lipoxygenases, lysozymes, mannanases, oxidases, pectate lyases, pectin acetyl esterases, pectinases, pentosanases, perhydrolases, peroxidases, phenoloxidases, phosphatases, phospholipases, phytases, polygalacturonases, proteases, pullulanases, reductases, rhannogalacturonases, beta-glucanases, tannases, transglutaminases, xylan acetyl-esterases, xylanases, xyloglucanases, xylosidases, metalloproteases, nucleases, additional serine proteases, and combinations thereof. 17 . The composition of claim 13 , wherein said composition contains phosphate or is phosphate-free and/or contains boron or is boron-free. 18 . The composition of claim 13 , wherein said composition does not contain a protease stabilizer. 19 . The composition of claim 13 , wherein said composition is a granular, powder, solid, bar, liquid, tablet, gel, paste or unit dose composition. 20 . A method of cleaning, comprising contacting a surface or an item in need of cleaning with the subtilisin variant of claim 1 ; and optionally further comprising the step of rinsing said surface or item after contacting said surface or item with said variant, wherein, optionally, said item is dishware or fabric. 21 . The composition according to claim 14 , wherein said enzyme composition is an enzyme granule.

Assignees

Inventors

Classifications

  • Preparations containing enzymes {, e.g. protease or amylase} · CPC title

  • Subtilisin (3.4.21.62) · CPC title

  • containing enzymes other than protease, amylase, lipase, cellulase, oxidase or reductase · CPC title

  • C12N9/54Primary

    bacteria being Bacillus · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12509672B2 cover?
Disclosed herein is one or more subtilisin variant, nucleic acid encoding same, and compositions and methods related to the production and use thereof, including one or more subtilisin variant that has improved stability compared to one or more reference subtilisin.
Who is the assignee on this patent?
Danisco Us Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/54. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).